• Treatments in Europe

    This virtual roundtable will bring together leaders from across Europe and beyond to consider the question of how Alzheimer’s treatments are adopted. While regulators in Europe have approved the first generation of disease-modifying therapies, payers have yet to follow — in contrast to countries such as the US and Japan. The discussion will explore how advocates mobilise urgency around access to diagnostics and treatments and what strategies might help shift the policy debate and how collaboration across the field could help secure future adoption.

  • Policy Breakfast at AAIC

    This breakfast roundtable on 15 July 2026 will bring together leaders from across the field to explore what it will take to turn scientific progress into meaningful change for patients. As breakthroughs in diagnosis and treatment create real momentum, the discussion will examine how those advances can reach people in clinics, health systems and communities around the world.

  • October 2026

    The 2026 WDC Summit will bring together international and UK leaders to examine how dementia practice is changing as diagnosis moves earlier and new treatments and prevention strategies emerge. The programme will explore the implications of this shift for clinical pathways, system organisation, and the experience of individuals who may live for longer periods in early-stage disease. 

  • November 2026

    The World Dementia Council 2026 WDC China Summit will take place on 14–15 November 2026 in Guangzhou. This two-day meeting will convene leading clinicians, researchers, and health system decision-makers from across China alongside international experts. The programme addresses: earlier and more precise diagnosis supported by biomarkers and updated diagnostic criteria; treatment delivery; the growing role of prevention; and the use of data to support long-term care.